Insider · CIK 0001953666
Kevin G. Shaw
Files at NXTC (NextCure, Inc.). First filing -, latest -.
In brief
Kevin G. Shaw files SEC Form 4 as officer at NXTC (NextCure, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Kevin G. Shaw has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 30, 2026 | NXTC NextCure, Inc. | AGrant or award Employee Stock Option (Right to Buy)derivative | +8,270 | $0.00 | $0 | 8,270 | Feb 3, 2026 |
| Jan 31, 2024 | NXTC NextCure, Inc. | AGrant or award Employee Stock Option (Right to Buy)derivative | +66,125 | $0.00 | $0 | 66,125 | Feb 1, 2024 |
Questions about Kevin G. Shaw
Answered from the filings on this page, as of the latest one.
Is Kevin G. Shaw buying or selling?
Kevin G. Shaw has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Kevin G. Shaw's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Kevin G. Shaw has 0.
Where does Kevin G. Shaw file Form 4?
Kevin G. Shaw has filed Form 4 at NXTC (NextCure, Inc.) as Sr VP, General Counsel. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.